Refine
Year of publication
Document Type
- Preprint (668)
- Article (385)
- Book (2)
- Conference Proceeding (1)
- Working Paper (1)
Has Fulltext
- yes (1057)
Is part of the Bibliography
- no (1057)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- ALICE experiment (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- COVID-19 (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- pp collisions (3)
- Beauty production (2)
- Bodensee (2)
- Bodensee-Gebiet (2)
- Charm physics (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Heavy Quark Production (2)
- Konstanz (2)
- Landkreis Konstanz (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QCD (2)
- SARS-CoV-2 (2)
- Single electrons (2)
- Tierökologie (2)
- influenza (2)
- out-patient paediatrics (2)
- respiratory tract infection (2)
- 1-propanol (1)
- 900 GeV (1)
- ALICE detector (1)
- Alcohol (1)
- Allergen immunotherapy (1)
- Allergoid (1)
- Anti-nuclei (1)
- Antiretroviral therapy (1)
- Antiretrovirals (1)
- Boosted Jets (1)
- Breast cancer (1)
- Breast tumors (1)
- Cancer detection and diagnosis (1)
- Cell binding (1)
- Cell staining (1)
- Centrality Class (1)
- Centrality Selection (1)
- Chemical composition (1)
- Cirrhosis (1)
- Collective Flow, (1)
- Comparison with QCD (1)
- Cumulative dose (1)
- Curvilinear dose response (1)
- Demolition emissions (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- European Union (1)
- European registry for idiopathic pulmonary fibrosis (eurIPFreg) (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Flohkrebse (1)
- Flow cytometry (1)
- Forschung (1)
- Genetic causes of cancer (1)
- Genetic testing (1)
- Grass pollen (1)
- HBT (1)
- HIV (1)
- HIV-1 (1)
- HNO (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hard Scattering (1)
- Hazard assessment (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Hepatitis C virus (1)
- Hepatocellular carcinoma (1)
- Histology (1)
- Human genetics (1)
- Idiopathic pulmonary fibrosis (IPF) (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Interstitial lung diseases (ILD) (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Jet Physics (1)
- Jet Substructure (1)
- Kupffer cells (1)
- Lehre (1)
- Liver diseases (1)
- Liver transplantation (1)
- Macrophages (1)
- Material budget (1)
- Methanol (1)
- Method validation (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Monte Carlo (1)
- Mouse models (1)
- Multi-Parton Interactions (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Muscheln (1)
- Neural network (1)
- Nuclear modification factor (1)
- ORL (1)
- Oncology (1)
- Otorhinolaryngology (1)
- Ovarian cancer (1)
- PM10 (1)
- PYTHIA (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Post-offence drinking (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton–proton (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Rapidity Range (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Research (1)
- Residency (1)
- Resolution Parameter (1)
- Risk assessment (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- See (1)
- Single muons (1)
- Size distribution (1)
- Specialist training (1)
- Sustainable chemistry (1)
- Systematic Uncertainty (1)
- TR (1)
- Teaching (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Ultrafine particles (1)
- University hospitals (1)
- Universitätskliniken (1)
- Urban aerosol (1)
- Vector Boson Production (1)
- Wasservögel (1)
- Weiterbildung (1)
- Xenon-based gas mixture (1)
- adenocarcinoma (1)
- allergen immunotherapy (1)
- birch pollen allergoid (1)
- central nervous system infection (1)
- cumulative dose (1)
- dE/dx (1)
- detector (1)
- diagnosis (1)
- dose response curve (1)
- experimental results (1)
- guideline (1)
- heavy ion experiments (1)
- immunocompromised patient (1)
- interferon regulatory factor 9 (IRF9) (1)
- lung cancer (1)
- quark gluon plasma (1)
- spectra (1)
- treatment (1)
- tumor microenvironment (TME) (1)
- type I interferons (IFNs) (1)
- versican (VCAN) (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1028)
- Frankfurt Institute for Advanced Studies (FIAS) (958)
- Informatik (924)
- Medizin (19)
- Geowissenschaften (4)
- Informatik und Mathematik (3)
- Biowissenschaften (2)
- Hochschulrechenzentrum (2)
- Biochemie und Chemie (1)
- Center for Financial Studies (CFS) (1)
Transcription factors can serve as links between tumor microenvironment signaling and oncogenesis. Interferon regulatory factor 9 (IRF9) is recruited and expressed upon interferon stimulation and is dependent on cofactors that exert in tumor-suppressing or oncogenic functions via the JAK-STAT pathway. IRF9 is frequently overexpressed in human lung cancer and is associated with decreased patient survival; however, the underlying mechanisms remain to be elucidated. Here, we used stably transduced lung adenocarcinoma cell lines (A549 and A427) to overexpress or knockdown IRF9. Overexpression led to increased oncogenic behavior in vitro, including enhanced proliferation and migration, whereas knockdown reduced these effects. These findings were confirmed in vivo using lung tumor xenografts in nude mice, and effects on both tumor growth and tumor mass were observed. Using RNA sequencing, we identified versican (VCAN) as a novel downstream target of IRF9. Indeed, IRF9 and VCAN expression levels were found to be correlated. We showed for the first time that IRF9 binds at a newly identified response element in the promoter region of VCAN to regulate its transcription. Using an siRNA approach, VCAN was found to enable the oncogenic properties (proliferation and migration) of IRF9 transduced cells, perhaps with CDKN1A involvement. The targeted inhibition of IRF9 in lung cancer could therefore be used as a new treatment option without multimodal interference in microenvironment JAK-STAT signaling.
Erratum for: Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells.Journal of biological chemistry, 2002 Nov 15;277(46):43623-30. doi: 10.1074/jbc.M203926200. Epub 2002 Sep 5.
Aim: It can be challenging to distinguish COVID-19 in children from other common infections. We set out to determine the rate at which children consulting a primary care paediatrician with an acute infection are infected with SARS-CoV-2 and to compare distinct findings. Method: In seven out-patient clinics, children aged 0–13 years with any new respiratory or gastrointestinal symptoms and presumed infection were invited to be tested for SARS-CoV-2. Factors that were correlated with testing positive were determined. Samples were collected from 25 January 2021 to 01 April 2021. Results: Seven hundred and eighty-three children participated in the study (median age 3 years and 0 months, range 1 month to 12 years and 11 months). Three hundred and fifty-eight were female (45.7%). SARS-CoV-2 RNA was detected in 19 (2.4%). The most common symptoms in children with as well as without detectable SARS-CoV-2 RNA were rhinitis, fever and cough. Known recent exposure to a case of COVID-19 was significantly correlated with testing positive, but symptoms or clinical findings were not. Conclusion: COVID-19 among the children with symptoms of an acute infection was uncommon, and the clinical presentation did not differ significantly between children with and without evidence of an infection with SARS-CoV-2.
In PC12 cells, a well studied model for neuronal differentiation, an elevation in the intracellular cAMP level increases cell survival, stimulates neurite outgrowth, and causes activation of extracellular signal-regulated protein kinase 1 and 2 (ERK1/2). Here we show that an increase in the intracellular cAMP concentration induces tyrosine phosphorylation of two receptor tyrosine kinases, i.e. the epidermal growth factor (EGF) receptor and the high affinity receptor for nerve growth factor (NGF), also termed Trk(A). cAMP-induced tyrosine phosphorylation of the EGF receptor is rapid and correlates with ERK1/2 activation. It occurs also in Panc-1, but not in human mesangial cells. cAMP-induced tyrosine phosphorylation of the NGF receptor is slower and correlates with Akt activation. Inhibition of EGF receptor tyrosine phosphorylation, but not of the NGF receptor, reduces cAMP-induced neurite outgrowth. Expression of dominant-negative Akt does not abolish cAMP-induced survival in serum-free media, but increases cAMP-induced ERK1/2 activation and neurite outgrowth. Together, our results demonstrate that cAMP induces dual signaling in PC12 cells: transactivation of the EGF receptor triggering the ERK1/2 pathway and neurite outgrowth; and transactivation of the NGF receptor promoting Akt activation and thereby modulating ERK1/2 activation and neurite outgrowth.
Erratum in: Correction: Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells. Journal of biological chemistry 2020 Oct 23;295(43):14792. doi: 10.1074/jbc.AAC120.016177.
Activation of TRPC6 channels is essential for lung ischaemia–reperfusion induced oedema in mice
(2012)
Lung ischaemia–reperfusion-induced oedema (LIRE) is a life-threatening condition that causes pulmonary oedema induced by endothelial dysfunction. Here we show that lungs from mice lacking nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox2y/−) or the classical transient receptor potential channel 6 (TRPC6−/−) are protected from LIR-induced oedema (LIRE). Generation of chimeric mice by bone marrow cell transplantation and endothelial-specific Nox2 deletion showed that endothelial Nox2, but not leukocytic Nox2 or TRPC6, are responsible for LIRE. Lung endothelial cells from Nox2- or TRPC6-deficient mice showed attenuated ischaemia-induced Ca2+ influx, cellular shape changes and impaired barrier function. Production of reactive oxygen species was completely abolished in Nox2y/− cells. A novel mechanistic model comprising endothelial Nox2-derived production of superoxide, activation of phospholipase C-γ, inhibition of diacylglycerol (DAG) kinase, DAG-mediated activation of TRPC6 and ensuing LIRE is supported by pharmacological and molecular evidence. This mechanism highlights novel pharmacological targets for the treatment of LIRE.
In this study we report the set-up of a novel twin chamber technique that uses the comparative method and establishes an appropriate connection of atmospheric and laboratory methods to broaden the tools for investigations. It is designed to study the impact of certain parameters and gases on ambient processes, such as particle formation online, and can be applied in a large variety of conditions. The characterisation of both chambers proved that both chambers operate identically, with a residence time xT (COMPASS1) = 26.5 ± 0.3 min and xT (COMPASS2) = 26.6 ± 0.4 min, at a typical flow rate of 15 L min−1 and a gas leak rate of (1.6 ± 0.8) × 10−5 s−1. Particle loss rates were found to be larger (due to the particles' stickiness to the chamber walls), with an extrapolated maximum of 1.8 × 10−3 s−1 at 1 nm, i.e. a hundredfold of the gas leak rate. This latter value is associated with sticky non-volatile gaseous compounds, too. Comparison measurement showed no significant differences. Therefore operation under atmospheric conditions is trustworthy. To indicate the applicability and the benefit of the system, a set of experiments was conducted under different conditions, i.e. urban and remote, enhanced ozone and terpenes as well as reduced sunlight. In order to do so, an ozone lamp was applied to enhance ozone in one of two chambers; the measurement chamber was protected from radiation by a first-aid cover and volatile organic compounds (VOCs) were added using a small additional flow and a temperature-controlled oven. During the elevated ozone period, ambient particle number and volume increased substantially at urban and remote conditions, but by a different intensity. Protection of solar radiation displayed a clear negative effect on particle number, while terpene addition did cause a distinct daily pattern. E.g. adding β pinene particle number concentration rose by 13% maximum at noontime, while no significant effect was observable during darkness. Therefore, the system is a useful tool for investigating local precursors and the details of ambient particle formation at surface locations as well as potential future feedback processes.
The anthropogenic influence on climate and environment has increased strongly since industrialization about 150 yr ago. The consequences for the atmosphere became more and more apparent and nowadays affect our life quality on Earth progressively. Because of that it is very important to understand the atmospheric processes, on which these effects are based on, in detail. In this study we report the set-up of a novel twin chamber technique that uses the comparative method and establishes an appropriate connection of atmospheric and laboratory methods to broaden the tools for investigations. It is designed to study the impact of certain parameters and gases on ambient processes such as particle formation online and can be applied in a large variety of conditions. The characterisation of both chambers proved that both chambers operate identically with a residence time (xT (COMPASS 1) = 26.5 ± 0.3 min and xT (COMPASS 2) = 26.6 ± 0.4 min) at a typical flow rate of 15 L min−1 and a deposition rate (1.6 ± 0.8) × 10−5 s−1. Comparison measurement showed no significant differences. Therefore operation under atmospheric conditions is trustworthy. To indicate the applicability and the benefit of the system a set of experiments was conducted at different conditions, i.e. urban and remote, enhancing ozone and terpenes as well as reducing sunlight. In the ozone enhanced ambient particle number and volume increased substantially at urban and remote conditions in a different strength. Solar radiation displayed a clear positive effect on particle number as well as terpene addition did at remote conditions. Therefore the system is a useful tool to investigate local precursors, the details of ambient particle formation at surface locations as well as future feedback processes.
Einleitung: Für angehende Ärztinnen und Ärzte sind gründliche biochemische Kenntnisse von großer Bedeutung für das Verständnis molekularer Mechanismen, physiologischer Abläufe und pathologischer Entwicklungen. Entsprechend nimmt die biochemische Lehre im vorklinischen Abschnitt des Medizinstudiums viel Zeit in Anspruch. Zugleich ist aber die Biochemie bei den Studienanfängern ein ungeliebtes Fach: Die Stofffülle, die Komplexität molekularer Prozesse, das geforderte hohe Abstraktionsniveau und die oft unzureichenden schulischen Vorkenntnisse führen bei vielen Erstsemestern zu tiefer Abneigung gegenüber der molekularen Medizin. Um diesem Problem zu begegnen, bieten wir den Medizinstudierenden der Johann Wolfgang Goethe-Universität als vorklinisches Wahlfach eine neuartige Lehrveranstaltung an, die multimedial-biografische Vorträge mit biochemischem Unterricht kombiniert.
Methodik: Das Institut für Biochemie am FB Medizin führt eine propädeutische Lehrveranstaltung durch, in der Biografien bekannter Persönlichkeiten ebenso wie die korrespondierenden Krankheiten vorgestellt werden. Konzipiert als Wahlpflichtfach bietet diese multimediale Lehrveranstaltung (Titel: "Leben und Leiden berühmter Persönlichkeiten. Eine Einführung in die molekulare Medizin") den 40 teilnehmenden Studierenden in zehn wöchentlichen Doppelsitzungen pro Studienjahr einen breitgefächerten Lernstoff mit drei Lernzielen:
1. Im ersten Teil (45 Min.) jeder Doppelsitzung werden Leben, Leiden und Werk berühmter Persöhnlichkeiten aus Literatur, Musik, Politik, Kunst, Sport und Wissenschaft vorgestellt, die an einer bekannten Krankheit litten bzw. leiden. Unterstützt wird dieser biografische Vortrag in der Regel durch multimediale Einspielungen kurzer Video-Clips oder Musikstücke.
2. Im zweiten Teil (75 Min.) werden die molekularmedizinischen Hintergründe dieser Erkrankungen in einem biochemischen Vortrag vermittelt.
3. Dieser Vortrag wird durch Kurzreferate (jeweils 5 min.) der Studierenden zu grundlegenden biochemischen Strukturen und Prozessen ergänzt.
Unter den regelmäßig angebotenen Doppel-Themen sind: der Rockmusiker Freddy Mercury (AIDS), der Schriftsteller Ernest Hemingway (Alkoholismus), der Rock ´n Roll-Sänger Elvis Presley (Diabetes), der Komponist Ludwig van Beethoven (Morbus Crohn), der Boxer Muhammad Ali (Morbus Parkinson), der Rockmusiker Frank Zappa (Krebs).
Ergebnisse: Die Vortragsreihe wurde seit 2005 zum vierten Mal durchgeführt. Die Evaluation durch die Teilnehmer mittels Fragebogen ergab durchweg eine gute bis sehr gute Gesamtbewertung. Der Lernerfolg für die biochemischen Grundlagen wurde hoch eingeschätzt. Die multimedial präsentierten Biografien wurden als sinnvolle Ergänzung zu den molekularmedizinischen Themen empfunden.
Schlussfolgerung: Das studentische Feed-back bestätigt die Vermutung, dass diese spezifische Kombination die Attraktivität und Akzeptanz von Biochemie und Molekularbiologie bei den Studienanfängern erheblich steigert.
Background: The Birch Allergoid, Tyrosine Adsorbate, Monophosphoryl Lipid A (POLLINEX® Quattro Plus 1.0 ml Birch 100%) is an effective, well‐tolerated short course subcutaneous immunotherapy. We performed 2 phase II studies to determine its optimal cumulative dose.
Methods: The studies were conducted in Germany, Austria and Poland (EudraCT numbers: 2012‐004336‐28 PQBirch203 and 2015‐000984‐15 PQBirch204) using a wide range of cumulative doses. In both studies, subjects were administered 6 therapy injections weekly outside the pollen season. Conjunctival Provocation Tests were performed at screening, baseline and 3‐4 weeks after completing treatment, to quantify the reduction in Total Symptom Scores (as the primary endpoint) with each cumulative dose. Multiple Comparison Procedure and Modeling analysis was used to test for the dose response, shape of the curve and estimation of the median effective dose (ED50), a measure of potency.
Results: Statistically significant dose responses (P < .01 & .001) were seen, respectively. The highest cumulative dose in PQBirch204 (27 300 standardized units [SU]) approached a plateau. Potency of the PQBirch was demonstrated by an ED50 2723 SU, just over half the current dose. Prevalence of treatment‐emergent adverse events was similar for active doses, most being short‐lived and mild. Compliance was over 85% in all groups.
Conclusion: Increasing the cumulative dose of PQBirch 5.5‐fold from 5100 to 27 300 SU achieved an absolute point difference from placebo of 1.91, a relative difference 32.3% and an increase in efficacy of 50%, without compromising safety. The cumulative dose response was confirmed to be curvilinear in shape.
Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing
(2019)
Background: Pollinex Quattro Grass (PQ Grass) is an effective, well-tolerated, short pre-seasonal subcutaneous immunotherapy to treat seasonal allergic rhinoconjunctivitis (SAR) due to grass pollen. In this Phase II study, 4 cumulative doses of PQ Grass and placebo were evaluated to determine its optimal cumulative dose.
Methods: Patients with grass pollen-induced SAR were randomised to either a cumulative dose of PQ Grass (5100, 14400, 27600 and 35600 SU) or placebo, administered as 6 weekly subcutaneous injections over 31–41 days (EudraCT number 2017-000333-31). Standardized conjunctival provocation tests (CPT) using grass pollen allergen extract were performed at screening, baseline and post-treatment to determine the total symptom score (TSS) assessed approximately 4 weeks after dosing. Three models were pre-defined (Emax, logistic, and linear in log-dose model) to evaluate a dose response relationship.
Results: In total, 95.5% of the 447 randomized patients received all 6 injections. A highly statistically significant (p < 0.0001), monotonic dose response was observed for all three pre-specified models. All treatment groups showed a statistically significant decrease from baseline in TSS compared to placebo, with the largest decrease observed after 27600 SU (p < 0.0001). The full course of 6 injections was completed by 95.5% of patients. Treatment-emergent adverse events were similar across PQ Grass groups, and mostly mild and transient in nature.
Conclusions: PQ Grass demonstrated a strong curvilinear dose response in TSS following CPT without compromising its safety profile.